Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Promising animal data reported for Mitsui Toatsu cerebroprotectant

June 6, 1997

Olanzapine superior to haloperidol against negative symptoms in schizophrenia

June 6, 1997

Body weight positively correlated with cognitive performance in AD

June 6, 1997

FDA approves generic version of Diamox

June 6, 1997

Antiamnesic effects of RU-47231 in rats

June 5, 1997

Transgenic mouse model of AD developed by Canadian researchers

June 5, 1997

Pfizer sponsors Canadian study of drug treatment in later stages of AD

June 5, 1997

Efficacy of chronic treatment with tolcapone + levodopa in Parkinson's disease

June 5, 1997

New use for ondansetron tested in clinical trials

June 5, 1997

Novel antiparkinsonian agent in development at Kyowa Hakko

June 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...